Animal Stem Cell Therapy Industry Research Report 2024

Animal Stem Cell Therapy Industry Research Report 2024


Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

Highlights

The global Animal Stem Cell Therapy market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Market competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Animal Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Stem Cell Therapy.
The Animal Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Medivet Biologics LLC
VETSTEM BIOPHARMA
J-ARM
U.S. Stem Cell, Inc
VetCell Therapeutics
Celavet Inc.
Magellan Stem Cells
Kintaro Cells Power
Animal Stem Care
Animal Cell Therapies
Cell Therapy Sciences
Animacel

Product Type Insights

Global markets are presented by Animal Stem Cell Therapy type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Animal Stem Cell Therapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Animal Stem Cell Therapy segment by Type

Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others Animals

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Animal Stem Cell Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Animal Stem Cell Therapy market.
Animal Stem Cell Therapy Segment by Application

Veterinary Hospitals
Research Organizations

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Animal Stem Cell Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Animal Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Animal Stem Cell Therapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Stem Cell Therapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Animal Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Animal Stem Cell Therapy by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
1.2.2 Dogs Stem Cell Therapy
1.2.3 Horses Stem Cell Therapy
1.2.4 Others Animals
2.3 Animal Stem Cell Therapy by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Veterinary Hospitals
2.3.3 Research Organizations
2.4 Assumptions and Limitations
3 Animal Stem Cell Therapy Breakdown Data by Type
3.1 Global Animal Stem Cell Therapy Historic Market Size by Type (2019-2024)
3.2 Global Animal Stem Cell Therapy Forecasted Market Size by Type (2025-2030)
4 Animal Stem Cell Therapy Breakdown Data by Application
4.1 Global Animal Stem Cell Therapy Historic Market Size by Application (2019-2024)
4.2 Global Animal Stem Cell Therapy Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Animal Stem Cell Therapy Market Perspective (2019-2030)
5.2 Global Animal Stem Cell Therapy Growth Trends by Region
5.2.1 Global Animal Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Animal Stem Cell Therapy Historic Market Size by Region (2019-2024)
5.2.3 Animal Stem Cell Therapy Forecasted Market Size by Region (2025-2030)
5.3 Animal Stem Cell Therapy Market Dynamics
5.3.1 Animal Stem Cell Therapy Industry Trends
5.3.2 Animal Stem Cell Therapy Market Drivers
5.3.3 Animal Stem Cell Therapy Market Challenges
5.3.4 Animal Stem Cell Therapy Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Animal Stem Cell Therapy Players by Revenue
6.1.1 Global Top Animal Stem Cell Therapy Players by Revenue (2019-2024)
6.1.2 Global Animal Stem Cell Therapy Revenue Market Share by Players (2019-2024)
6.2 Global Animal Stem Cell Therapy Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Animal Stem Cell Therapy Head office and Area Served
6.4 Global Animal Stem Cell Therapy Players, Product Type & Application
6.5 Global Animal Stem Cell Therapy Players, Date of Enter into This Industry
6.6 Global Animal Stem Cell Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Animal Stem Cell Therapy Market Size (2019-2030)
7.2 North America Animal Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Animal Stem Cell Therapy Market Size by Country (2019-2024)
7.4 North America Animal Stem Cell Therapy Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Animal Stem Cell Therapy Market Size (2019-2030)
8.2 Europe Animal Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Animal Stem Cell Therapy Market Size by Country (2019-2024)
8.4 Europe Animal Stem Cell Therapy Market Size by Country (2025-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Animal Stem Cell Therapy Market Size (2019-2030)
9.2 Asia-Pacific Animal Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Animal Stem Cell Therapy Market Size by Country (2019-2024)
9.4 Asia-Pacific Animal Stem Cell Therapy Market Size by Country (2025-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Animal Stem Cell Therapy Market Size (2019-2030)
10.2 Latin America Animal Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Animal Stem Cell Therapy Market Size by Country (2019-2024)
10.4 Latin America Animal Stem Cell Therapy Market Size by Country (2025-2030)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Animal Stem Cell Therapy Market Size (2019-2030)
11.2 Middle East & Africa Animal Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Animal Stem Cell Therapy Market Size by Country (2019-2024)
11.4 Middle East & Africa Animal Stem Cell Therapy Market Size by Country (2025-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Medivet Biologics LLC
11.1.1 Medivet Biologics LLC Company Detail
11.1.2 Medivet Biologics LLC Business Overview
11.1.3 Medivet Biologics LLC Animal Stem Cell Therapy Introduction
11.1.4 Medivet Biologics LLC Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.1.5 Medivet Biologics LLC Recent Development
11.2 VETSTEM BIOPHARMA
11.2.1 VETSTEM BIOPHARMA Company Detail
11.2.2 VETSTEM BIOPHARMA Business Overview
11.2.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Introduction
11.2.4 VETSTEM BIOPHARMA Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.2.5 VETSTEM BIOPHARMA Recent Development
11.3 J-ARM
11.3.1 J-ARM Company Detail
11.3.2 J-ARM Business Overview
11.3.3 J-ARM Animal Stem Cell Therapy Introduction
11.3.4 J-ARM Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.3.5 J-ARM Recent Development
11.4 U.S. Stem Cell, Inc
11.4.1 U.S. Stem Cell, Inc Company Detail
11.4.2 U.S. Stem Cell, Inc Business Overview
11.4.3 U.S. Stem Cell, Inc Animal Stem Cell Therapy Introduction
11.4.4 U.S. Stem Cell, Inc Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.4.5 U.S. Stem Cell, Inc Recent Development
11.5 VetCell Therapeutics
11.5.1 VetCell Therapeutics Company Detail
11.5.2 VetCell Therapeutics Business Overview
11.5.3 VetCell Therapeutics Animal Stem Cell Therapy Introduction
11.5.4 VetCell Therapeutics Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.5.5 VetCell Therapeutics Recent Development
11.6 Celavet Inc.
11.6.1 Celavet Inc. Company Detail
11.6.2 Celavet Inc. Business Overview
11.6.3 Celavet Inc. Animal Stem Cell Therapy Introduction
11.6.4 Celavet Inc. Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.6.5 Celavet Inc. Recent Development
11.7 Magellan Stem Cells
11.7.1 Magellan Stem Cells Company Detail
11.7.2 Magellan Stem Cells Business Overview
11.7.3 Magellan Stem Cells Animal Stem Cell Therapy Introduction
11.7.4 Magellan Stem Cells Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.7.5 Magellan Stem Cells Recent Development
11.8 Kintaro Cells Power
11.8.1 Kintaro Cells Power Company Detail
11.8.2 Kintaro Cells Power Business Overview
11.8.3 Kintaro Cells Power Animal Stem Cell Therapy Introduction
11.8.4 Kintaro Cells Power Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.8.5 Kintaro Cells Power Recent Development
11.9 Animal Stem Care
11.9.1 Animal Stem Care Company Detail
11.9.2 Animal Stem Care Business Overview
11.9.3 Animal Stem Care Animal Stem Cell Therapy Introduction
11.9.4 Animal Stem Care Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.9.5 Animal Stem Care Recent Development
11.10 Animal Cell Therapies
11.10.1 Animal Cell Therapies Company Detail
11.10.2 Animal Cell Therapies Business Overview
11.10.3 Animal Cell Therapies Animal Stem Cell Therapy Introduction
11.10.4 Animal Cell Therapies Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.10.5 Animal Cell Therapies Recent Development
11.11 Cell Therapy Sciences
11.11.1 Cell Therapy Sciences Company Detail
11.11.2 Cell Therapy Sciences Business Overview
11.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Introduction
11.11.4 Cell Therapy Sciences Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.11.5 Cell Therapy Sciences Recent Development
11.12 Animacel
11.12.1 Animacel Company Detail
11.12.2 Animacel Business Overview
11.12.3 Animacel Animal Stem Cell Therapy Introduction
11.12.4 Animacel Revenue in Animal Stem Cell Therapy Business (2017-2022)
11.12.5 Animacel Recent Development
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings